Skip to main content
. 2022 Aug 23;36(5):549–571. doi: 10.1007/s40259-022-00549-3

Fig. 4.

Fig. 4

Chemical modification patterns of small interfering RNAs approved for clinical use: patisiran, givosiran, inclisiran, lumasiran, and vutrisiran. Modifications are indicated by colored circles, and phosphorothioate modifications are highlighted as well; see the lower panel for an explanation of the symbols.

Adapted from Hu et al. [27]